-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation
-
Update on recent trials in the treatment of hereditary angioedema
Neelu Kalra,Timothy Craig
Review Article: Clinical Investigation